Acne

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.

Studies suggest that the presence of acne makes sleep issues more likely, but results on the impact of acne severity on sleep vary across research.

Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.

Prescription of isotretinoin is a challenging endeavor, requiring collaboration between providers, office administrative staff, pharmacists, insurance companies, and laboratory facilities.

Parental acne has “significant” associations with presentation and a predisposition to moderate to severe disease, but acne in siblings is a better indicator of the likelihood of grade 3 to 4 scarring, reported a recent study.

A recent study found that influencers and retailers dominate #acne on the platform.

Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.

Advances ranging from combined laser and drug therapies to innovative devices mean patients with acne no longer have to be scared of permanent scarring.

Joshua Zeichner, MD, discusses how important it is to treat acne properly and gives a tip about moisturizers and topical retinoids.

A common complaint in puberty, hormonal acne also affects skin health and quality of life for adults of all genders, driving the need for new solutions.

A look at the types of visits and treatments prescribed via teledermatology during the pandemic reinforces the staying power of virtual acne care; statistics offer key details.

Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.

Two new studies analyzes the competencies and limitations of teaching a neural network to recognize facial acne.

An expert takes a look at both modalities in treating acne scarring, wrinkles, pigmentation issues, and actinic keratoses.

Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.

In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.

Teenagers were the most likely to be affected by targeted misinformation.

Is rosacea being confused with acne? Are physicians treating the their patients with the patient's expectations in mind? Questions like these are more are answered by Adebola Dele-Michael, MD.

For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.

A clinician updates the conventional wisdom on acne’s variations in patients of color, offering pearls from her practice and practical takeaways from recent research.

Gina Mangin, PA-C, and James Treat, MD, dive into the intricacies of acne and rosacea, going beyond the surface of both skin conditions and giving important treatment tips at the 2022 New Wave Dermatology Conference.

In the world of pediatric dermatology, many skin conditions can have parents concerned about their children’s condition. Lisa Swanson, MD, explains how to better address their questions at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium.

There is a theory that professional acne care can be effective not only in decreasing clinical signs but also in improving quality of life.

The education on how to treat patients with skin issues in this group needs to be expanded so physicians can better treat their patients.

In a presentation at the recent AAD annual meeting, Diane M. Thiboutot, MD, discusses the potential risks of antibiotic resistance in acne management.

Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.

Clascoterone cream 1% phase 3 results presented at meeting.

Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.

In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.

Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.